Cargando…

Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome

Despite the improvements in prognostication of the revised International Prognostic Scoring System (IPSS-R) in myelodysplastic syndrome (MDS), there remain a portion of patients with lower risk (low/intermediate risk, LR) but poor prognostics. This study aimed to evaluate the relative contribution o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Ying, Guo, Juan, Wu, Dong, Wu, Ling-Yun, Song, Lu-Xi, Zhang, Zheng, Zhao, You-Shan, Chang, Chun-Kang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839382/ https://www.ncbi.nlm.nih.gov/pubmed/33520721 http://dx.doi.org/10.3389/fonc.2020.610525

Ejemplares similares

Editorial: Risk-stratification in myelodysplastic syndromes
por: Breccia, Massimo, et al.
Publicado: (2022)

Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome
por: Corrao, Kristen, et al.
Publicado: (2022)

Single-Nucleotide Polymorphism Array Technique Generating Valuable Risk-Stratification Information for Patients With Myelodysplastic Syndromes
por: Xiao, Xia, et al.
Publicado: (2020)

Correlation Between Bone Marrow Blasts Counts With Flow Cytometry and Morphological Analysis in Myelodysplastic Syndromes
por: Huang, Min, et al.
Publicado: (2017)

Lymphoid aggregates in the bone marrow biopsies of patients with myelodysplastic syndromes – A potential prognostic marker?
por: Book, Reut, et al.
Publicado: (2023)

Risk stratification in therapy-related myelodysplastic syndromes
por: Zeidan, Amer M.
Publicado: (2017)

WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Giudice, Valentina, et al.
Publicado: (2021)

Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in Myelodysplastic Syndromes
por: Bains, Amanpreet Kaur, et al.
Publicado: (2022)

Recombinant Human Thrombopoietin Accelerates the Recovery of Platelet in Patients With Lower-Risk Myelodysplastic Syndrome: A Proof-of-Concept Study
por: Yang, Yuan, et al.
Publicado: (2021)

The implication of identifying JAK2(V617F) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis
por: Olsen, Randall J., et al.
Publicado: (2008)

Bone marrow niches in myelodysplastic syndromes
por: Tosato, Giovanna, et al.
Publicado: (2021)

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
por: Mosquera Orgueira, Adrian, et al.
Publicado: (2023)

Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
por: Moia, Riccardo, et al.
Publicado: (2021)

A Deep Learning Model for the Automatic Recognition of Aplastic Anemia, Myelodysplastic Syndromes, and Acute Myeloid Leukemia Based on Bone Marrow Smear
por: Wang, Meifang, et al.
Publicado: (2022)

Methylation-based reclassification and risk stratification of skull-base chordomas
por: Huo, Xulei, et al.
Publicado: (2022)

Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts
por: Kasprzak, A., et al.
Publicado: (2022)

Bone Marrow Immunity and Myelodysplasia
por: Lambert, Claude, et al.
Publicado: (2016)

Global Proteomics Analysis of Bone Marrow: Establishing Talin-1 and Centrosomal Protein of 55 kDa as Potential Molecular Signatures for Myelodysplastic Syndromes
por: Moura, Arlindo A., et al.
Publicado: (2022)

Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification
por: Mahmood, Rafia, et al.
Publicado: (2018)

Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update
por: Jain, Akriti G., et al.
Publicado: (2022)

Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes
por: Kouroukli, Olga, et al.
Publicado: (2022)

Can Risk Stratification Based on Ultrasound Elastography of Background Liver Assist CEUS LI-RADS in the Diagnosis of HCC?
por: Li, Jiawu, et al.
Publicado: (2021)

Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation
por: Salhotra, Amandeep, et al.
Publicado: (2023)

Risk Stratification in Oral Cancer: A Novel Approach
por: Tu, Irene Wen-Hui, et al.
Publicado: (2022)

PTCL, NOS: An update on classification, risk-stratification, and treatment
por: Weiss, Jonathan, et al.
Publicado: (2023)

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis
por: Chys, Brecht, et al.
Publicado: (2020)

Comparison of Different Risk-Stratification Systems for the Diagnosis of Benign and Malignant Thyroid Nodules
por: Shen, Yan, et al.
Publicado: (2019)

Can intensity of long-term follow-up for survivors of childhood and teenage cancer be determined by therapy-based risk stratification?
por: Edgar, A B, et al.
Publicado: (2013)

Management of patients with lower-risk myelodysplastic syndromes
por: Brunner, Andrew M., et al.
Publicado: (2022)

Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients
por: Wu, Yuenv, et al.
Publicado: (2017)

A Prediction Model Intended for Exploratory Laparoscopy Risk Stratification in Colorectal Cancer Patients With Potential Occult Peritoneal Metastasis
por: Zhang, Yuanxin, et al.
Publicado: (2022)

The yin-yang of immunity: Immune dysregulation in myelodysplastic syndrome with different risk stratification
por: Peng, Xiaohuan, et al.
Publicado: (2022)

Improved risk stratification by PET-based intratumor heterogeneity in children with high-risk neuroblastoma
por: Li, Chao, et al.
Publicado: (2022)

Retrospective validation of bone risk stratification criteria for men with de novo metastatic hormone-naive prostate cancer in China
por: Zhang, Yang, et al.
Publicado: (2023)

The growth of myelodysplastic bone marrow in long-term cultures.
por: Borbenyi, Z., et al.
Publicado: (1987)

Editorial: Prognosis prediction and risk stratification in head and neck cancer
por: Li, Tengxiang, et al.
Publicado: (2022)

Editorial: Identification, risk stratification, and optimized management for Lynch Syndrome
por: Bernstein, Inge, et al.
Publicado: (2023)

Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia
por: Kenealy, Melita, et al.
Publicado: (2019)

Vacuolated Blasts in the Bone Marrow of a Child with Rhabdomyosarcoma
por: Ataseven, Eda, et al.
Publicado: (2020)

Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes
por: Jiang, Lingxu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8ateolku8sg3avgptpqa0uk71f